David V Conti

发表

Hierarchical Bayes prioritization of marker associations from a genome‐wide association scan for further investigation

James W Baurley, Juan Pablo Lewinger, David V Conti, 2007, Genetic epidemiology.

Discovery of complex pathways from observational data

David V Conti, Duncan C Thomas, W James Gauderman, 2010, Statistics in medicine.

Complex system approaches to genetic analysis Bayesian approaches.

James W Baurley, David V Conti, Duncan C Thomas, 2010, Advances in genetics.

Using Bayes model averaging to leverage both gene main effects and G × E interactions to identify genomic regions in genome‐wide association studies

Juan Pablo Lewinger, David V Conti, Lilit C Moss, 2019, Genetic epidemiology.

Detecting gene-environment interactions using a combined case-only and case-control approach.

David V Conti, Dalin Li, D. Conti, 2008, American journal of epidemiology.

Methodological Issues in Multistage Genome-wide Association Studies.

Juan Pablo Lewinger, David V Conti, Duncan C Thomas, 2009, Statistical science : a review journal of the Institute of Mathematical Statistics.

Whole-exome sequencing of over 4100 men of African ancestry and prostate cancer risk.

Swapan Mallick, Bogdan Pasaniuc, David V Conti, 2016, Human molecular genetics.

Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrence.

David V Conti, María Elena Martínez, D. Mount, 2010, Cancer research.

Incorporating model uncertainty in detecting rare variants: the Bayesian risk index

David V Conti, D. Thomas, D. Conti, 2011, Genetic epidemiology.

The contribution of rare variation to prostate cancer heritability

Swapan Mallick, Bogdan Pasaniuc, Douglas F. Easton, 2015 .

Identifying susceptibility genes by using joint tests of association and linkage and accounting for epistasis

David V Conti, W James Gauderman, Joshua Millstein, 2005, BMC Genetics.

Sample size requirements to detect gene‐environment interactions in genome‐wide association studies

Juan Pablo Lewinger, David V Conti, W James Gauderman, 2011, Genetic epidemiology.

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

Peter Kraft, Jenny Donovan, Anssi Auvinen, 2014, Nature Genetics.

Association of prostate cancer risk and aggressiveness to androgen pathway genes: SRD5A2, CYP17, and the AR

David V Conti, John S Witte, Graham Casey, 2004, The Prostate.

Confounding and heterogeneity in genetic association studies with admixed populations.

Juan Pablo Lewinger, David V Conti, W James Gauderman, 2013, American journal of epidemiology.

Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.

Steven Gallinger, Peter Kraft, Nazneen Rahman, 2016, Cancer research.

Meta-analysis of 8q24 for seven cancers reveals a locus between NOV and ENPP2 associated with cancer development

Steven Gallinger, David V Conti, Honglin Song, 2011, BMC Medical Genetics.

Discovery of common and rare genetic risk variants for colorectal cancer

Mathieu Lemire, Steven Gallinger, Michael Wainberg, 2018, Nature Genetics.

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

Nawaid Usmani, Suzanne Chambers, Martin Eklund, 2018, Nature Communications.

Commentary: the concept of 'Mendelian Randomization'.

David V Conti, D. Conti, D. Thomas, 2004, International journal of epidemiology.

A testing framework for identifying susceptibility genes in the presence of epistasis.

David V Conti, W James Gauderman, Joshua Millstein, 2006, American journal of human genetics.

Genetic ancestry influences asthma susceptibility and lung function among Latinos.

David V Conti, W James Gauderman, Esteban G Burchard, 2015, The Journal of allergy and clinical immunology.

Testing association between disease and multiple SNPs in a candidate gene

David V Conti, W James Gauderman, Frank Gilliland, 2007, Genetic epidemiology.

Use of pathway information in molecular epidemiology

David V Conti, James Baurley, Cornelia M Ulrich, 2009, Human Genomics.

Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk.

David V Conti, Honglin Song, Malcolm C Pike, 2011, Human molecular genetics.